| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.009 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |